Ph.D., Chief Scientific Officer and VP of Research and Development, Argos Therapeutics
Charles A. Nicolette, Ph.D. has served as Chief Scientific Officer since December 2007 and as Vice President of Research and Development since December 2004. Dr. Nicolette served as Vice President of Research from July 2003 to December 2004. Prior to joining Argos, Dr. Nicolette served in various positions at Genzyme Molecular Oncology, Inc., a biotechnology company, from 1997 to 2003, most recently as Director of Antigen Discovery. Dr. Nicolette received a B.S. from the State University of New York at Stony Brook and a Ph.D. in biochemistry and cellular and developmental biology from the State University of New York at Stony Brook, completing his doctoral dissertation and post-doctoral fellowship at Cold Spring Harbor Laboratory.